These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2477546)

  • 1. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
    Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J
    J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Phenylethyl ester and 2-phenylethyl amide derivative analogues of the C-terminal hepta- and octapeptide of cholecystokinin.
    Fulcrand P; Rodriguez M; Galas MC; Lignon MF; Laur J; Aumelas A; Martinez J
    Int J Pept Protein Res; 1988 Nov; 32(5):384-95. PubMed ID: 2463231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
    Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
    J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity.
    Galas MC; Lignon MF; Rodriguez M; Mendre C; Fulcrand P; Laur J; Martinez J
    Am J Physiol; 1988 Feb; 254(2 Pt 1):G176-82. PubMed ID: 2450468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists.
    Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM
    J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and biological activity of 2-phenylethyl ester analogues of C-terminal heptapeptide of cholecystokinin modified in Trp 30 region.
    Rolland M; Rodriguez M; Lignon MF; Galas MC; Laur J; Aumelas A; Martinez J
    Int J Pept Protein Res; 1991 Aug; 38(2):181-92. PubMed ID: 1723720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activities of some cholecystokinin analogues substituted in position 29 by a beta-alanine.
    Rodriguez M; Rolland M; Lignon MF; Galas MC; Laur J; Aumelas A; Martinez J
    Int J Pept Protein Res; 1989 Nov; 34(5):394-404. PubMed ID: 2482263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological activity of cholecystokinin analogues modified in the Met28-Gly29 region.
    Mendre C; Rodriguez M; Lignon MF; Galas MC; Gueudet C; Worms P; Martinez J
    Eur J Pharmacol; 1990 Sep; 186(2-3):213-22. PubMed ID: 1705230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.
    Rodriguez M; Lignon MF; Galas MC; Amblard M; Martinez J
    Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synthetic peptide derivative that is a cholecystokinin receptor antagonist.
    Lignon MF; Galas MC; Rodriguez M; Laur J; Aumelas A; Martinez J
    J Biol Chem; 1987 May; 262(15):7226-31. PubMed ID: 2438274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.
    Gonzalez-Muniz R; Bergeron F; Marseigne I; Durieux C; Roques BP
    J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
    Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
    J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatum.
    Mendre C; Rodriquez M; Gueudet C; Lignon MF; Galas MC; Laur J; Worms P; Martinez J
    J Biol Chem; 1988 Aug; 263(22):10641-5. PubMed ID: 3392031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD; Knight M; Sutliff VE; Jensen RT
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
    Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
    Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors.
    Rodriguez M; Amblard M; Galas MC; Lignon MF; Aumelas A; Martinez J
    Int J Pept Protein Res; 1990 May; 35(5):441-51. PubMed ID: 2376470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of tryptophan-modified analogues of cholecystokinin-octapeptide with cholecystokinin receptors on pancreatic acini.
    Adachi H; Rajh HM; Tesser GI; de Pont JJ; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1981 Dec; 678(3):358-63. PubMed ID: 6172157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N alpha-carboxyacyl analogues of CCK with a substituted Gly: interaction with pancreatic and gallbladder CCK receptors.
    von Schrenck T; Müller K; Schulze C; Mirau S; Raedler A; Greten H
    Peptides; 1993; 14(6):1309-15. PubMed ID: 7510882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin (pancreozymin). 4. Synthesis and properties of a biologically active analogue of the C-terminal heptapeptide with epsilon-hydroxynorleucine sulfate replacing tyrosine sulfate.
    Bodanszky M; Martinez J; Priestley GP; Gardner JD; Mutt V
    J Med Chem; 1978 Oct; 21(10):1030-5. PubMed ID: 722712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini.
    Sarri E; Ramos B; Salido GM; Claro E
    Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.